SCHEMBL13667299

SCHEMBL13667299

N#Cc1ccc(Br)cc1N=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.45
▸ MAOB P27338 3/20 0.42
▸ MAOA P21397 2/20 0.42
▸ SLC1A5 Q15758 1/20 0.38
▸ CHEK1 O14757 1/20 0.36
▸ MCL1 Q07820 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ GPR35 Q9HC97 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21159847 0.78 MAOB (0.34) LMNAMAOBMAOAMAPK1ALDH1A1
SCHEMBL13063629 0.76 VCAM1 (0.49) LMNAMAOBMAOACHEK1MCL1
SCHEMBL28254037 0.76 AR (0.39) MCL1SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL13361828 0.76 TRPV4 (0.38) MAOBMAOAMAPK1NPSR1CYP11B1
SCHEMBL30475151 0.73 MAOB (0.61) MAOBMAOASLC1A5CHEK1MCL1
SCHEMBL1395661 0.73 MAOB (0.61) MAOBMAOASLC1A5CHEK1MCL1
SCHEMBL21100112 0.72 ALDH1A1 (0.36) LMNASMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL13078047 0.72 KDM4E (0.46) MAOBL3MBTL1NPSR1KDM4EALDH1A1
SCHEMBL28194580 0.72 AR (0.44) CYP11B1CYP11B2KDM4E
SCHEMBL1343170 0.72 MAOB (0.48) LMNAMAOBMAOASLC1A5CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B LMNA 2473/4885MAOB 3445/4885MAOA 3957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback